Literature DB >> 15143194

Jak3-independent trafficking of the common gamma chain receptor subunit: chaperone function of Jaks revisited.

Sigrun R Hofmann1, Albert Q Lam, Stephan Frank, Yong-Jie Zhou, Haydeé L Ramos, Yuka Kanno, Davide Agnello, Richard J Youle, John J O'Shea.   

Abstract

Janus kinases (Jaks) play an essential role in cytokine signaling and have been reported to regulate plasma membrane expression of their cognate receptors. In this study, we examined whether Jak3 and the common gamma chain (gamma(c)) reciprocally regulate their plasma membrane expression. In contrast to interleukin-2Ralpha, gamma(c) localized poorly to the plasma membrane and accumulated in endosomal-lysosomal compartments. However, gamma(c) was expressed at comparable levels on the surface of cells lacking Jak3, and plasma membrane turnover of gamma(c) was independent of Jak3. Nonetheless, overexpression of Jak3 enhanced accumulation of gamma(c) at the plasma membrane. Without gamma(c), Jak3 localized in the cytosol, whereas in the presence of the receptor, it colocalized with gamma(c) in endosomes and at the plasma membrane. Although the Jak FERM domain is necessary and sufficient for receptor binding, the requirement for full-length Jak3 in gamma(c) membrane trafficking was remarkably stringent; using truncation and deletion mutants, we showed that the entire Jak3 molecule was required, although kinase activity was not. Thus, unlike other cytokine receptors, gamma(c) does not require Jak3 for receptor membrane expression. However, full-length Jak3 is required for normal trafficking of this cytokine receptor/Jak pair, a finding that has important structural and clinical implications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15143194      PMCID: PMC416416          DOI: 10.1128/MCB.24.11.5039-5049.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  37 in total

1.  Unexpected effects of FERM domain mutations on catalytic activity of Jak3: structural implication for Janus kinases.

Authors:  Y J Zhou; M Chen; N A Cusack; L H Kimmel; K S Magnuson; J G Boyd; W Lin; J L Roberts; A Lengi; R H Buckley; R L Geahlen; F Candotti; M Gadina; P S Changelian; J J O'Shea
Journal:  Mol Cell       Date:  2001-11       Impact factor: 17.970

Review 2.  Cytokine signaling in 2002: new surprises in the Jak/Stat pathway.

Authors:  John J O'Shea; Massimo Gadina; Robert D Schreiber
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

Review 3.  Signaling by type I and II cytokine receptors: ten years after.

Authors:  M Gadina; D Hilton; J A Johnston; A Morinobu; A Lighvani; Y J Zhou; R Visconti; J J O'Shea
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

Review 4.  The protein kinase complement of the human genome.

Authors:  G Manning; D B Whyte; R Martinez; T Hunter; S Sudarsanam
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

Review 5.  Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.

Authors:  L D Notarangelo; P Mella; A Jones; G de Saint Basile; G Savoldi; T Cranston; M Vihinen; R F Schumacher
Journal:  Hum Mutat       Date:  2001-10       Impact factor: 4.878

6.  Mapping of a region within the N terminus of Jak1 involved in cytokine receptor interaction.

Authors:  C Haan; H Is'harc; H M Hermanns; H Schmitz-Van De Leur; I M Kerr; P C Heinrich; J Grötzinger; I Behrmann
Journal:  J Biol Chem       Date:  2001-07-23       Impact factor: 5.157

7.  Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.

Authors:  Simone Radtke; Heike M Hermanns; Claude Haan; Hildegard Schmitz-Van De Leur; Hugues Gascan; Peter C Heinrich; Iris Behrmann
Journal:  J Biol Chem       Date:  2002-01-10       Impact factor: 5.157

8.  A cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradation.

Authors:  L Supino-Rosin; A Yoshimura; H Altaratz; D Neumann
Journal:  Eur J Biochem       Date:  1999-07

9.  The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor.

Authors:  L J Huang; S N Constantinescu; H F Lodish
Journal:  Mol Cell       Date:  2001-12       Impact factor: 17.970

10.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

View more
  19 in total

Review 1.  Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Authors:  Christopher J Carbone; Serge Y Fuchs
Journal:  J Cell Biochem       Date:  2014-01       Impact factor: 4.429

2.  Janus kinase 2 activation mechanisms revealed by analysis of suppressing mutations.

Authors:  Henrik M Hammarén; Anniina T Virtanen; Bobin George Abraham; Heidi Peussa; Stevan R Hubbard; Olli Silvennoinen
Journal:  J Allergy Clin Immunol       Date:  2018-08-06       Impact factor: 10.793

Review 3.  The common γ-chain cytokine receptor: tricks-and-treats for T cells.

Authors:  Adam T Waickman; Joo-Young Park; Jung-Hyun Park
Journal:  Cell Mol Life Sci       Date:  2015-10-14       Impact factor: 9.261

4.  Two domains of the erythropoietin receptor are sufficient for Jak2 binding/activation and function.

Authors:  Stéphane Pelletier; Sébastien Gingras; Megumi Funakoshi-Tago; Sherié Howell; James N Ihle
Journal:  Mol Cell Biol       Date:  2006-09-18       Impact factor: 4.272

5.  Ligand-independent homomeric and heteromeric complexes between interleukin-2 or -9 receptor subunits and the gamma chain.

Authors:  Yaniv Malka; Tekla Hornakova; Yohan Royer; Laurent Knoops; Jean-Christophe Renauld; Stefan N Constantinescu; Yoav I Henis
Journal:  J Biol Chem       Date:  2008-10-01       Impact factor: 5.157

Review 6.  Modulation of growth hormone receptor abundance and function: roles for the ubiquitin-proteasome system.

Authors:  Stuart J Frank; Serge Y Fuchs
Journal:  Biochim Biophys Acta       Date:  2008-06-09

Review 7.  Targeting the JAK/STAT Pathway in T Cell Lymphoproliferative Disorders.

Authors:  Geoffrey Shouse; Liana Nikolaenko
Journal:  Curr Hematol Malig Rep       Date:  2019-12       Impact factor: 3.952

8.  Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.

Authors:  K G Suresh Kumar; Bentley Varghese; Anamika Banerjee; Darren P Baker; Stefan N Constantinescu; Sandra Pellegrini; Serge Y Fuchs
Journal:  J Biol Chem       Date:  2008-05-12       Impact factor: 5.157

9.  Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration.

Authors:  Sijo Mathew; Sudeep P George; Yaohong Wang; Mohammad Rizwan Siddiqui; Kamalakkannan Srinivasan; Langzhu Tan; Seema Khurana
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

10.  Type I IL-4Rs selectively activate IRS-2 to induce target gene expression in macrophages.

Authors:  Nicola M Heller; Xiulan Qi; Ilkka S Junttila; Kari Ann Shirey; Stefanie N Vogel; William E Paul; Achsah D Keegan
Journal:  Sci Signal       Date:  2008-12-23       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.